Dividend Assets Capital LLC maintained its position in Colgate-Palmolive Co. (NYSE:CL) during the second quarter, Holdings Channel reports. The firm owned 7,705 shares of the company’s stock at the end of the second quarter. Dividend Assets Capital LLC’s holdings in Colgate-Palmolive were worth $564,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of CL. Tompkins Financial Corp increased its stake in shares of Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock worth $124,000 after buying an additional 930 shares during the last quarter. Arcadia Investment Management Corp MI increased its stake in shares of Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock worth $132,000 after buying an additional 400 shares during the last quarter. FCM Investments TX acquired a new stake in shares of Colgate-Palmolive during the second quarter worth about $132,000. Orrstown Financial Services Inc. increased its stake in shares of Colgate-Palmolive by 26.7% in the second quarter. Orrstown Financial Services Inc. now owns 2,280 shares of the company’s stock worth $167,000 after buying an additional 480 shares during the last quarter. Finally, Gilman Hill Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth about $202,000. Institutional investors and hedge funds own 72.97% of the company’s stock.
Shares of Colgate-Palmolive Co. (NYSE:CL) traded down 0.70% during midday trading on Monday, reaching $73.62. The company’s stock had a trading volume of 2,691,080 shares. The firm has a market capitalization of $65.63 billion, a PE ratio of 47.41 and a beta of 0.63. Colgate-Palmolive Co. has a 1-year low of $61.40 and a 1-year high of $75.38. The company’s 50-day moving average price is $73.63 and its 200 day moving average price is $72.42.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.01. The company had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a return on equity of 1,980.28% and a net margin of 9.04%. The company’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period last year, the business posted $0.70 EPS. On average, equities research analysts forecast that Colgate-Palmolive Co. will post $2.80 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 15th. Stockholders of record on Monday, October 24th will be issued a $0.39 dividend. The ex-dividend date is Thursday, October 20th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.12%. Colgate-Palmolive’s dividend payout ratio (DPR) is 100.65%.
A number of analysts recently issued reports on CL shares. Bank of America Corp. raised Colgate-Palmolive from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $70.86 to $80.00 in a research report on Monday, September 12th. JPMorgan Chase & Co. reaffirmed a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a research report on Friday, July 29th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $76.00 target price (up from $74.00) on shares of Colgate-Palmolive in a research report on Friday, July 15th. Finally, Exane BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a research report on Friday, July 29th. Fourteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $74.68.
In other news, SVP John J. Huston sold 14,000 shares of the stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $74.93, for a total value of $1,049,020.00. Following the completion of the sale, the senior vice president now owns 102,761 shares in the company, valued at $7,699,881.73. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Patricia Verduin sold 3,834 shares of the stock in a transaction dated Thursday, September 15th. The shares were sold at an average price of $71.85, for a total value of $275,472.90. Following the completion of the sale, the insider now owns 55,013 shares of the company’s stock, valued at approximately $3,952,684.05. The disclosure for this sale can be found here. 1.05% of the stock is owned by insiders.
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Co. (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related companies with MarketBeat.com's FREE daily email newsletter.